Maternal and Clinical Outcomes of Placenta Accreta Spectrum: Insights from a Retrospective Study in Bahrain
Open Access
Abstract
Placenta accreta spectrum (PAS) refers to a group of abnormal placental attachments in which the placenta adheres too deeply to the uterine wall, with varying degrees of invasion classified as accreta, increta, or percreta. Increased rates of uterine surgeries, advanced maternal age, and cesarean deliveries have all contributed to an increase in the incidence of PAS. Complications associated with PAS can lead to severe intrapartum or postpartum hemorrhage, hysterectomy, and significant maternal morbidity, making early diagnosis and management crucial for improving outcomes. Understanding the epidemiology and risk factors of PAS is crucial for developing early detection protocols and preventive strategies. Localized data, particularly from Bahrain, can inform targeted care approaches and optimize resource allocation, ultimately leading to improved clinical guidelines, enhanced patient education, and better healthcare outcomes for affected women. There are growing concerns about the impact of PAS on maternal health and healthcare resources in Bahrain, similar to trends observed in other regions. To improve patient education and management strategies, it is essential to comprehend the regional patterns, characteristics, and outcomes associated with PAS. However, the absence of comprehensive data specific to Bahrain hinders effective clinical decision-making and policy development. Addressing this gap is imperative for advancing maternal healthcare in the region.Keywords
Funding Information
- Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain)
This publication has 35 references indexed in Scilit:
- Conservative management of placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2025
- Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine‐scar dehiscenceUltrasound in Obstetrics & Gynecology, 2024
- Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrumAmerican Journal of Obstetrics and Gynecology, 2021
- Cesarean Scar PregnancyObstetrics and Gynecology Clinics of North America, 2019
- Placenta percreta is associated with more frequent severe maternal morbidity than placenta accretaAmerican Journal of Obstetrics and Gynecology, 2018
- FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management,International Journal of Gynecology & Obstetrics, 2018
- FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology,International Journal of Gynecology & Obstetrics, 2018
- Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over timeAmerican Journal of Obstetrics and Gynecology, 2017
- Center of excellence for placenta accretaAmerican Journal of Obstetrics and Gynecology, 2015
- Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysisUltrasound in Obstetrics & Gynecology, 2014